Cargando…
Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches
Angiotensin-converting enzyme (ACE) converts angiotensin I to angiotensin II which causes vasoconstriction. ACE inhibitors reduce blood pressure by inhibiting ACE. A well-known adverse drug reaction to ACE inhibitors is ACE inhibitor-induced angioedema (ACEi-AE). Angioedema is a swelling of skin and...
Autores principales: | Ali, Haivin Aziz, Lomholt, Anne Fog, Hamidreza Mahmoudpour, Seyed, Hermanrud, Thorbjørn, Bygum, Anette, von Buchwald, Christian, Jakobsen, Marianne Antonius, Rasmussen, Eva Rye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844479/ https://www.ncbi.nlm.nih.gov/pubmed/31710633 http://dx.doi.org/10.1371/journal.pone.0224858 |
Ejemplares similares
-
Correction: Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches
por: Ali, Haivin Aziz, et al.
Publicado: (2019) -
The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema
por: Hermanrud, Thorbjørn, et al.
Publicado: (2016) -
Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital
por: Pall, Amalie Hartvig, et al.
Publicado: (2020) -
Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema
por: Rasmussen, Eva Rye, et al.
Publicado: (2017) -
Corrigendum to “Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema”
por: Rasmussen, Eva Rye, et al.
Publicado: (2018)